Clinical trials recruiting for Leptomeningeal Disease
3
Recruiting trials
4
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Capecitabine tablets | 1 |
| High-dose Methotrexate (8 gm/m2; HD-MTX) | 1 |
| Nivolumab | 1 |
| Trastuzumab | 1 |
| Trastuzumab Injection | 1 |
| Tucatinib Oral Tablet | 1 |
| cDC1 Vaccine | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 1 |
| Maryland | 1 |
| Missouri | 1 |
| North Carolina | 1 |
Top cities
Self-screener
Recruiting trials
- Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
- Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Related conditions
Trials recruiting for Leptomeningeal Disease often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Metastatic breast cancer 131Leptomeningeal Metastasis 12HER2-positive Metastatic Breast Cancer 8
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Leptomeningeal Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.